Dialysis
Scientists at Washington University, Medical Department report research in dialysis
Published in Medical Letter on the CDC and FDA, July 27th, 2008
"Management of anemia in chronic kidney disease (CKD) and dialysis patients with erythropoiesis stimulating agents continues to be an area of debate. Recent US Food and Drug Administration documents indicate that Normal Hematocrit Study (NHS) completed in 1996 had more patients (1265 vs. 1233) and showed significantly increased deaths or myocardial infarctions (p = 0.01; risk ratio: 1.28; 95% CI: 1.06-1.56) rather than the indeterminate evidence of harm (risk ratio: 1.30; 95% CI: 0.9-1.9) reported in the 1998 publication," scientists in the United States report.
"This review places the NHS study results in context with the other three major anemia trials, which,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Scripps Research Institute
Scripps research scientists reveal key structure from ebola virus - Cancer
New findings from A.L. Harzstark and co-researchers in the area of cancer described - HIV/AIDS
Research results from State University of New York update knowledge of HIV/AIDS - HIV/AIDS
Studies from University of California in the area of HIV/AIDS published - HIV/AIDS
Studies from University of Siena yield new information about HIV/AIDS - Huntington Disease
New findings reported from University of Cambridge describe advances in Huntington disease - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
